Artificial intelligence predicts clinically relevant atrial high-rate episodes in patients with cardiac implantable electronic devices.

Journal: Scientific reports
PMID:

Abstract

To assess the utility of machine learning (ML) algorithms in predicting clinically relevant atrial high-rate episodes (AHREs), which can be recorded by a pacemaker. We aimed to develop ML-based models to predict clinically relevant AHREs based on the clinical parameters of patients with implanted pacemakers in comparison to logistic regression (LR). We included 721 patients without known atrial fibrillation or atrial flutter from a prospective multicenter (11 tertiary hospitals) registry comprising all geographical regions of Korea from September 2017 to July 2020. Predictive models of clinically relevant AHREs were developed using the random forest (RF) algorithm, support vector machine (SVM) algorithm, and extreme gradient boosting (XGB) algorithm. Model prediction training was conducted by seven hospitals, and model performance was evaluated using data from four hospitals. During a median follow-up of 18 months, clinically relevant AHREs were noted in 104 patients (14.4%). The three ML-based models improved the discrimination of the AHREs (area under the receiver operating characteristic curve: RF: 0.742, SVM: 0.675, and XGB: 0.745 vs. LR: 0.669). The XGB model had a greater resolution in the Brier score (RF: 0.008, SVM: 0.008, and XGB: 0.021 vs. LR: 0.013) than the other models. The use of the ML-based models in patient classification was associated with improved prediction of clinically relevant AHREs after pacemaker implantation.

Authors

  • Min Kim
    Department of Neurology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Younghyun Kang
    Medtronic Korea, Seoul, Korea.
  • Seng Chan You
    Department of Biomedical Informatics, Ajou University School of Medicine, Suwon, South Korea.
  • Hyung-Deuk Park
    Medtronic Korea, Seoul, Korea.
  • Sang-Soo Lee
    Institute for Skeletal Aging and Orthopedic Surgery, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon-si, Gangwon-do, Republic of Korea.
  • Tae-Hoon Kim
    Interaction Laboratory of Advanced Technology Research Center, Korea University of Technology and Education, Cheonan, Chungcheongnam-do 31253, Republic of Korea.
  • Hee Tae Yu
    Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
  • Eue-Keun Choi
    Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Hyoung-Seob Park
    Division of Cardiology, Keimyung University Hospital, Daegu, Korea.
  • Junbeom Park
    Department of Cardiology, Ewha Womans University Hospital, Seoul, Korea.
  • Young Soo Lee
    Division of Cardiology, Daegu Catholic University Hospital, Daegu, Korea.
  • Ki-Woon Kang
    Division of Cardiology, Eulji University Hospital, Daejeon, Korea.
  • Jaemin Shim
    Cardiovascular Center, Korea University Medical Center, Seoul, Korea (the Republic of).
  • Jung-Hoon Sung
    Department of Cardiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
  • Il-Young Oh
    Department of Internal Medicine, Seoul National University, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. Electronic address: spy510@snu.ac.kr.
  • Jong Sung Park
    Division of Cardiology, Dong-A University Hospital, 26 Daesingongwon-ro, Seo-gu, Busan, 49201, Republic of Korea. thinkmed@dae.ac.krm.
  • Boyoung Joung
    Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea. cby6908@yuhs.ac.